nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—SLC6A1—amyotrophic lateral sclerosis	0.816	1	CbGaD
Tiagabine—SLC6A1—hindbrain—amyotrophic lateral sclerosis	0.0067	0.284	CbGeAlD
Tiagabine—SLC6A1—brainstem—amyotrophic lateral sclerosis	0.00384	0.163	CbGeAlD
Tiagabine—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0192	CcSEcCtD
Tiagabine—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0183	CcSEcCtD
Tiagabine—SLC6A1—medulla oblongata—amyotrophic lateral sclerosis	0.00268	0.113	CbGeAlD
Tiagabine—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0167	CcSEcCtD
Tiagabine—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.0025	0.016	CcSEcCtD
Tiagabine—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.0025	0.016	CcSEcCtD
Tiagabine—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0157	CcSEcCtD
Tiagabine—SLC6A1—spinal cord—amyotrophic lateral sclerosis	0.00239	0.101	CbGeAlD
Tiagabine—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00219	0.014	CcSEcCtD
Tiagabine—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00219	0.014	CcSEcCtD
Tiagabine—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0138	CcSEcCtD
Tiagabine—SLC6A1—nervous system—amyotrophic lateral sclerosis	0.00201	0.0852	CbGeAlD
Tiagabine—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0127	CcSEcCtD
Tiagabine—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0127	CcSEcCtD
Tiagabine—SLC6A1—central nervous system—amyotrophic lateral sclerosis	0.00194	0.0821	CbGeAlD
Tiagabine—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0123	CcSEcCtD
Tiagabine—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0121	CcSEcCtD
Tiagabine—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0121	CcSEcCtD
Tiagabine—SLC6A1—cerebellum—amyotrophic lateral sclerosis	0.00189	0.0802	CbGeAlD
Tiagabine—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00187	0.012	CcSEcCtD
Tiagabine—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0118	CcSEcCtD
Tiagabine—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0113	CcSEcCtD
Tiagabine—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0108	CcSEcCtD
Tiagabine—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0105	CcSEcCtD
Tiagabine—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0105	CcSEcCtD
Tiagabine—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0104	CcSEcCtD
Tiagabine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0099	CcSEcCtD
Tiagabine—SLC6A1—brain—amyotrophic lateral sclerosis	0.00154	0.0652	CbGeAlD
Tiagabine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00979	CcSEcCtD
Tiagabine—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00969	CcSEcCtD
Tiagabine—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00948	CcSEcCtD
Tiagabine—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00948	CcSEcCtD
Tiagabine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00882	CcSEcCtD
Tiagabine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00874	CcSEcCtD
Tiagabine—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00866	CcSEcCtD
Tiagabine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00849	CcSEcCtD
Tiagabine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00842	CcSEcCtD
Tiagabine—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00834	CcSEcCtD
Tiagabine—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00834	CcSEcCtD
Tiagabine—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00827	CcSEcCtD
Tiagabine—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00827	CcSEcCtD
Tiagabine—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00805	CcSEcCtD
Tiagabine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00798	CcSEcCtD
Tiagabine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00798	CcSEcCtD
Tiagabine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00772	CcSEcCtD
Tiagabine—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00765	CcSEcCtD
Tiagabine—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00753	CcSEcCtD
Tiagabine—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00735	CcSEcCtD
Tiagabine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00724	CcSEcCtD
Tiagabine—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00703	CcSEcCtD
Tiagabine—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00683	CcSEcCtD
Tiagabine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00678	CcSEcCtD
Tiagabine—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00673	CcSEcCtD
Tiagabine—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00664	CcSEcCtD
Tiagabine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00655	CcSEcCtD
Tiagabine—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00655	CcSEcCtD
Tiagabine—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00651	CcSEcCtD
Tiagabine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00651	CcSEcCtD
Tiagabine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00646	CcSEcCtD
Tiagabine—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.001	0.00642	CcSEcCtD
Tiagabine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.000985	0.0063	CcSEcCtD
Tiagabine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.000985	0.0063	CcSEcCtD
Tiagabine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000955	0.0061	CcSEcCtD
Tiagabine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.000949	0.00607	CcSEcCtD
Tiagabine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.000943	0.00603	CcSEcCtD
Tiagabine—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.000932	0.00596	CcSEcCtD
Tiagabine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00589	CcSEcCtD
Tiagabine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00589	CcSEcCtD
Tiagabine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00091	0.00582	CcSEcCtD
Tiagabine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0009	0.00575	CcSEcCtD
Tiagabine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.0009	0.00575	CcSEcCtD
Tiagabine—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.000875	0.00559	CcSEcCtD
Tiagabine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.000856	0.00547	CcSEcCtD
Tiagabine—Coma—Riluzole—amyotrophic lateral sclerosis	0.000851	0.00544	CcSEcCtD
Tiagabine—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.000842	0.00539	CcSEcCtD
Tiagabine—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.000842	0.00539	CcSEcCtD
Tiagabine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.000817	0.00522	CcSEcCtD
Tiagabine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.000809	0.00517	CcSEcCtD
Tiagabine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000809	0.00517	CcSEcCtD
Tiagabine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00512	CcSEcCtD
Tiagabine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00507	CcSEcCtD
Tiagabine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00507	CcSEcCtD
Tiagabine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000785	0.00502	CcSEcCtD
Tiagabine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000756	0.00483	CcSEcCtD
Tiagabine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000753	0.00481	CcSEcCtD
Tiagabine—Injury—Riluzole—amyotrophic lateral sclerosis	0.000736	0.0047	CcSEcCtD
Tiagabine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000729	0.00466	CcSEcCtD
Tiagabine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00072	0.0046	CcSEcCtD
Tiagabine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000717	0.00458	CcSEcCtD
Tiagabine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000711	0.00454	CcSEcCtD
Tiagabine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000696	0.00445	CcSEcCtD
Tiagabine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.000679	0.00434	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00432	CcSEcCtD
Tiagabine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00432	CcSEcCtD
Tiagabine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00432	CcSEcCtD
Tiagabine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.000671	0.00429	CcSEcCtD
Tiagabine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00426	CcSEcCtD
Tiagabine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00426	CcSEcCtD
Tiagabine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000661	0.00422	CcSEcCtD
Tiagabine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000653	0.00417	CcSEcCtD
Tiagabine—SLC6A1—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.000647	0.149	CbGpPWpGaD
Tiagabine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000643	0.00411	CcSEcCtD
Tiagabine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000641	0.0041	CcSEcCtD
Tiagabine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000636	0.00407	CcSEcCtD
Tiagabine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000629	0.00402	CcSEcCtD
Tiagabine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000624	0.00399	CcSEcCtD
Tiagabine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000618	0.00395	CcSEcCtD
Tiagabine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000616	0.00394	CcSEcCtD
Tiagabine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000599	0.00383	CcSEcCtD
Tiagabine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000597	0.00381	CcSEcCtD
Tiagabine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00374	CcSEcCtD
Tiagabine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00374	CcSEcCtD
Tiagabine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00374	CcSEcCtD
Tiagabine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000569	0.00364	CcSEcCtD
Tiagabine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000562	0.00359	CcSEcCtD
Tiagabine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000547	0.0035	CcSEcCtD
Tiagabine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00054	0.00345	CcSEcCtD
Tiagabine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00344	CcSEcCtD
Tiagabine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000534	0.00341	CcSEcCtD
Tiagabine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000532	0.0034	CcSEcCtD
Tiagabine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00338	CcSEcCtD
Tiagabine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000524	0.00335	CcSEcCtD
Tiagabine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00052	0.00332	CcSEcCtD
Tiagabine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000514	0.00329	CcSEcCtD
Tiagabine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000511	0.00327	CcSEcCtD
Tiagabine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000511	0.00327	CcSEcCtD
Tiagabine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00325	CcSEcCtD
Tiagabine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000507	0.00324	CcSEcCtD
Tiagabine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0005	0.00319	CcSEcCtD
Tiagabine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000497	0.00318	CcSEcCtD
Tiagabine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000492	0.00314	CcSEcCtD
Tiagabine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000489	0.00313	CcSEcCtD
Tiagabine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00047	0.00301	CcSEcCtD
Tiagabine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000469	0.003	CcSEcCtD
Tiagabine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000468	0.00299	CcSEcCtD
Tiagabine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000466	0.00298	CcSEcCtD
Tiagabine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000466	0.00298	CcSEcCtD
Tiagabine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000464	0.00297	CcSEcCtD
Tiagabine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000461	0.00295	CcSEcCtD
Tiagabine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00042	0.00268	CcSEcCtD
Tiagabine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000413	0.00264	CcSEcCtD
Tiagabine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000401	0.00257	CcSEcCtD
Tiagabine—Tension—Riluzole—amyotrophic lateral sclerosis	0.0004	0.00256	CcSEcCtD
Tiagabine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000399	0.00255	CcSEcCtD
Tiagabine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000396	0.00253	CcSEcCtD
Tiagabine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000394	0.00252	CcSEcCtD
Tiagabine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000392	0.0025	CcSEcCtD
Tiagabine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000382	0.00244	CcSEcCtD
Tiagabine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000378	0.00242	CcSEcCtD
Tiagabine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000376	0.00241	CcSEcCtD
Tiagabine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00239	CcSEcCtD
Tiagabine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00235	CcSEcCtD
Tiagabine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000366	0.00234	CcSEcCtD
Tiagabine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000365	0.00234	CcSEcCtD
Tiagabine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000365	0.00233	CcSEcCtD
Tiagabine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00036	0.0023	CcSEcCtD
Tiagabine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000358	0.00229	CcSEcCtD
Tiagabine—Cough—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00227	CcSEcCtD
Tiagabine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000352	0.00225	CcSEcCtD
Tiagabine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000347	0.00222	CcSEcCtD
Tiagabine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000347	0.00222	CcSEcCtD
Tiagabine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000347	0.00222	CcSEcCtD
Tiagabine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000346	0.00221	CcSEcCtD
Tiagabine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000343	0.00219	CcSEcCtD
Tiagabine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00217	CcSEcCtD
Tiagabine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000335	0.00214	CcSEcCtD
Tiagabine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000332	0.00213	CcSEcCtD
Tiagabine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00033	0.00211	CcSEcCtD
Tiagabine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000327	0.00209	CcSEcCtD
Tiagabine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000325	0.00208	CcSEcCtD
Tiagabine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000324	0.00207	CcSEcCtD
Tiagabine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000321	0.00205	CcSEcCtD
Tiagabine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000317	0.00203	CcSEcCtD
Tiagabine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000315	0.0133	CbGeAlD
Tiagabine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000311	0.00199	CcSEcCtD
Tiagabine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000303	0.0128	CbGeAlD
Tiagabine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000303	0.00194	CcSEcCtD
Tiagabine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000301	0.00192	CcSEcCtD
Tiagabine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000298	0.00191	CcSEcCtD
Tiagabine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00189	CcSEcCtD
Tiagabine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00189	CcSEcCtD
Tiagabine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000293	0.00187	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000291	0.067	CbGpPWpGaD
Tiagabine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000289	0.00185	CcSEcCtD
Tiagabine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000287	0.00183	CcSEcCtD
Tiagabine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000284	0.00182	CcSEcCtD
Tiagabine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000284	0.00182	CcSEcCtD
Tiagabine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000274	0.00175	CcSEcCtD
Tiagabine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000272	0.00174	CcSEcCtD
Tiagabine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000264	0.00169	CcSEcCtD
Tiagabine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000263	0.00168	CcSEcCtD
Tiagabine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000263	0.00168	CcSEcCtD
Tiagabine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000245	0.00157	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000245	0.0564	CbGpPWpGaD
Tiagabine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000239	0.00152	CcSEcCtD
Tiagabine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000235	0.0015	CcSEcCtD
Tiagabine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000227	0.00145	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000226	0.0521	CbGpPWpGaD
Tiagabine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00022	0.00141	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000218	0.0503	CbGpPWpGaD
Tiagabine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000211	0.00135	CcSEcCtD
Tiagabine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00021	0.00134	CcSEcCtD
Tiagabine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000209	0.00134	CcSEcCtD
Tiagabine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000208	0.00133	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0002	0.046	CbGpPWpGaD
Tiagabine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000197	0.00126	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000188	0.0432	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000186	0.0428	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000186	0.0428	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000177	0.0408	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000173	0.0399	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000167	0.0385	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000164	0.0378	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000153	0.0352	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00015	0.0347	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000142	0.0328	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000142	0.0328	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00014	0.0322	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000128	0.0296	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.99e-05	0.0207	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	8.1e-05	0.0187	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.64e-05	0.0176	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.64e-05	0.0176	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.1e-05	0.00485	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.41e-06	0.00217	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.28e-06	0.00214	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.21e-06	0.00166	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.21e-06	0.00166	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.59e-06	0.00152	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.13e-06	0.00141	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.76e-06	0.00133	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.21e-06	0.0012	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.95e-06	0.000911	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.65e-06	0.00084	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.99e-06	0.00069	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.61e-06	0.000371	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.48e-06	0.000341	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.22e-06	0.00028	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.34e-07	0.000192	CbGpPWpGaD
